
Otonomy OTIC
Quarterly report 2022-Q3
added 11-10-2022
Otonomy Total Inventories 2011-2026 | OTIC
Annual Total Inventories Otonomy
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | 227 K | - | - | 6 K | 1.44 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.44 M | 6 K | 556 K |
Quarterly Total Inventories Otonomy
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 455 K | 227 K | - | - | - | 478 K | - | - | - | - | - | - | - | 6 K | 1.24 M | 1.19 M | 1.2 M | 1.44 M | 1.44 M | 1.44 M | 1.44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 1.44 M | 6 K | 958 K |
Total Inventories of other stocks in the Biotechnology industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acorda Therapeutics
ACOR
|
16.2 M | - | -24.86 % | $ 820 K | ||
|
Alnylam Pharmaceuticals
ALNY
|
82.7 M | $ 327.37 | -1.81 % | $ 42.9 B | ||
|
Amphastar Pharmaceuticals
AMPH
|
177 M | $ 21.55 | -0.6 % | $ 1.01 B | ||
|
Akebia Therapeutics
AKBA
|
15.6 M | $ 1.42 | -8.71 % | $ 365 M | ||
|
Aquestive Therapeutics
AQST
|
6.17 M | $ 4.18 | -1.3 % | $ 447 M | ||
|
Arcutis Biotherapeutics
ARQT
|
22.6 M | $ 24.21 | -1.53 % | $ 3.08 B | ||
|
BioDelivery Sciences International
BDSI
|
23.7 M | - | -4.8 % | $ 255 M | ||
|
Autolus Therapeutics plc
AUTL
|
33.2 M | $ 1.52 | 1.68 % | $ 405 M | ||
|
BeiGene, Ltd.
BGNE
|
608 M | - | 0.49 % | $ 251 B | ||
|
Caladrius Biosciences
CLBS
|
1.27 M | - | -16.75 % | $ 25.8 M | ||
|
bluebird bio
BLUE
|
22.9 M | - | - | $ 546 M |